Informatie:
Fout:
ID
34333
Beschrijving
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01492127
Link
https://clinicaltrials.gov/show/NCT01492127
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatocellular Carcinoma NCT01492127
Eligibility Hepatocellular Carcinoma NCT01492127
- StudyEvent: Eligibility
Similar models
Eligibility Hepatocellular Carcinoma NCT01492127
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
cirrhotic patients with hepatocellular carcinoma proven by histological examination of a biopsy specimen, eligible for curative treatment (radiofrequency, surgical resection, liver transplantation)
boolean
ID.2
Item
patient able to give informed consent
boolean
ID.3
Item
patient with social security coverage
boolean
ID.4
Item
secondary liver tumors
boolean
ID.5
Item
non hepatocellular carcinoma primary liver tumor
boolean
ID.6
Item
hepatocellular carcinoma without cirrhosis
boolean
ID.7
Item
patients with hepatocellular carcinoma and cirrhosis not eligible for curative treatment
boolean
ID.8
Item
prisoners
boolean
ID.9
Item
adults under guardianship or curatorship
boolean
ID.10
Item
pregnancy
boolean